Lacidipine prevents the hypertension and renal and cardiac changes induced by high-fructose diet in WKY rats

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 3, 1999, Pages 485-491

  Cosenzi, Alessandro ^a   Sacerdote, Ariela ^a   Seculin, Paolo ^a   Odoni, Giulio ^a   Plazzotta, Nadia ^a   Bernobich, Elena ^a   Bellini, Giuseppe ^a,b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Blood pressure; Collagen III; Fibronectin; Fructose; Glomerular hypertrophy; Heart; Lacidipine

Indexed keywords

CALCIUM ANTAGONIST; COLLAGEN TYPE 3; CREATININE; FIBRONECTIN; FRUCTOSE; GLUCOSE; INSULIN; LACIDIPINE; NITRATE; NITRIC OXIDE; NITRITE; PLACEBO; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULOPATHY; HEART DISEASE; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; COLLAGEN; CREATININE; DIETARY CARBOHYDRATES; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRONECTINS; FRUCTOSE; HEART DISEASES; HYPERTENSION; INSULIN; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MYOCARDIUM; NITRIC OXIDE; ORGAN SIZE; RATS; RATS, INBRED WKY; TRIGLYCERIDES;

EID: 0033023753     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199903000-00020     Document Type: Article

References (34)

1. Hwang I-S, Ho H, Huffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10:512-6.
2. Kempe HP, Engelmann K, Gretz N, Hasslacher C. Models of diabetes for studying diabetic nephropathy. In: Gretz N, Strauch M, eds. Experimental and genetic rat models of chronic renal failure. Basel: Karger, 1993:148-55.
3. Thornburn DW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 1989;49:1155-63.
4. Reaven GM, Ho H, Hoffmann BB. Somatostatin inhibition of fructose-induced hypertension. Hypertension 1989;14:117-20.
5. Bönner G. Hyperinsulinemia, insulin resistance and hypertension. J Cardiovasc Pharmacol 1994;24(suppl 2):S39-49.
6. Valderrabano F, Jones EHP, Mallick NP. Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1993;10(suppl 5):1-25.
7. Aurell M, Björck S. Determinants of progressive renal disease in diabetes mellitus. Kidney Int 1992;41(suppl 36):S38-42.
8. Rosenmann E, Teitelbaum A, Cohen AM, Jerusalem MD. Nephropathy in sucrose-fed rats: electron and light microscopic studies. Diabetes 1971;20:803-10.
9. Kannel WB, Abbott RD. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction in the Framingham study. Am Heart J 1986;111:391-7.
10. Kobayashi R, Nagano M, Nakamura F, et al. Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats. Hypertension 1993;21:1051-5.
11. Bakris GL. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 1990;112:707-8.
12. Demarie BK, Bakris GL. Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 1990;113:987-8.
13. Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 1991:302:210-6.
14. Navarro-Cid J, Maeso R, Perez-Vizcaino F, et al. Effects of antihypertensive drugs on blood pressure and metabolic alterations in the fructose-induced hypertensive rats. Am J Hypertens 1996;9: 669-74.
15. 2+ channel blockade with mibefradil in hyperinsulinemic, insulin resistant and hypertensive rats. Cardiovasc Res 1997;34:121-8.
16. Snell FD, Snell CT. Nitrate in colorimetric methods of analysis. New York: Van Nostrand, 1949:798-9.
17. Navarro-Cid J, Maeso R, Perez-Vizcaino F, et al. Effects of losar-tan on blood pressure, metabolic alterations and vascular reactivity in the fructose-induced hypertensive rat. Hypertension 1996;26: 1074-8.
18. Berthault MF, Morin J, Dubar M, Ktorza A, Ferrè P, Penicaud L. Effets de la rilménidine chez le rat rendu insulinorésistant et hypertendu par un régime riche en fructose. Arch Mal Coeur Vaiss 1996;89:1103-6.
19. Sacerdote A, Cosenzi A, Bocin E, et al. Effects of losartan on blood pressure and left ventricular weight in fructose-fed rats. Am J Hypertens 1995;8(4 part 2):116A.
20. Sacerdote A, Cosenzi A, Bocin E, et al. Losartan prevents changes in blood pressure and glomerular size induced by high fructose diet in WKY rats. J Hypertens 1996;14:S187.
21. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307: 652-9.
22. Manitius J, Baines AD, Roszkiewicz A. The effects of high fructose intake on renal morphology and renal function in rats. J Physiol Pharmacol 1995;46:179-83.
23. Tikkanen I, Johnston CI. Comparison of renin-angiotensin to calcium channel blockade in renal disease. Kidney Int 1997;52(suppl 63):19-22.
24. Dworkin LD. Effects of calcium antagonists on glomerular hemodynamics and structure in experimental hypertension. Am J Kidney Dis 1991;5(S1):89-93.
25. Epstein M, Loutzenhiser R. Potential applicability of calcium antagonists as renal protective agents. In: Epstein M, Loutzenhiser R, eds. Calcium antagonists and the kidney. Philadelphia: Hanley & Belfus, 1990:275-98.
26. Godfraind T, salomone S. Calcium antagonists and endothelial function: focus on nitric oxide and endothelin. Cardiovasc Drug Ther 1996; 10:439-46.
27. Hynes RO. Fibronectins. New York: Springer Verlag, 1990.
28. Bank N, Aynedjian HS. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993;43:1306-12.
29. Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM. Abnormal renal haemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol 1995;265:886-95.
30. - in fructose fed hypertensive rats. In: European Society of Hypertension, ed. Book of abstracts: Seventh European Meeting on Hypertension. 9-12 June. Milan: Universitá di Milano, 1995:165.
31. Furberg CD, Psaty BM, Meyer JN. Nifedipine-dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1236-1.
32. Sen S, Tarazi RC, Bumpus FM. Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res 1977; 11:427-33.
33. Mukherjee D, Sen S. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats. Circ Res 1990;67:1474-80.
34. Ehrlich Y, Rosenthal T. Effect of angiotensin converting enzyme inhibitors on fructose-induced hypertension and hyperinsulinemia in rats. Clin Exp Pharmacol Physiol Suppl 1995;1:S347-9.